Pacis Michelle M, Fortin Chelsea N, Zarek Shvetha M, Mumford Sunni L, Segars James H
Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03756, USA.
J Assist Reprod Genet. 2015 Mar;32(3):323-35. doi: 10.1007/s10815-014-0407-9. Epub 2014 Dec 30.
To review the current literature regarding the role of vitamin D status in pregnancy outcomes in women undergoing assisted reproductive technology (ART) and to assess cost-effectiveness of routine vitamin D deficiency screening and repletion prior to initiation of ART.
A systematic literature review was conducted using PubMed. Relevant study outcomes were compared among the selected studies. A cost-benefit analysis was performed using a decision tree mathematical model with sensitivity analyses from the perspective of direct societal cost. Published data were used to estimate probabilities and costs in 2014 US dollars.
Thirty-four articles were retrieved, of which eight met inclusion criteria. One study demonstrated a negative relationship between vitamin D status and ART outcomes, while two studies showed no association. The remaining five studies concluded that ART outcomes improved after vitamin D repletion.
The majority of reviewed studies reported a decrement in ART outcomes in patients with vitamin D deficiency. Cost-benefit analyses suggested that screening and supplementing vitamin D prior to ART might be cost effective, but further evidence is needed. Given the absence of Level I evidence regarding vitamin D status and ART outcomes, full endorsement of routine vitamin D screening and supplementation prior to ART is premature.
回顾当前关于维生素D状态在接受辅助生殖技术(ART)的女性妊娠结局中的作用的文献,并评估在开始ART之前进行常规维生素D缺乏筛查和补充的成本效益。
使用PubMed进行系统的文献综述。在所选研究中比较相关的研究结果。使用决策树数学模型进行成本效益分析,并从直接社会成本的角度进行敏感性分析。已发表的数据用于估计以2014年美元计算的概率和成本。
检索到34篇文章,其中8篇符合纳入标准。一项研究表明维生素D状态与ART结局之间存在负相关,而两项研究表明无关联。其余五项研究得出结论,补充维生素D后ART结局有所改善。
大多数综述研究报告维生素D缺乏患者的ART结局下降。成本效益分析表明,在ART之前筛查和补充维生素D可能具有成本效益,但还需要进一步的证据。鉴于缺乏关于维生素D状态与ART结局的I级证据,在ART之前完全认可常规维生素D筛查和补充还为时过早。